Reported Reactions

Devices › Device types

FDA product code OQG · class 2 · Orthopedic

Hip prosthesis, semi-constrained, cemented, metal/polymer, + additive, porous, uncemented: medical device reports filed with FDA

673 reports carry this product code, 2004–2026; 3 brands with a page.

673
reports with this product code
0% of all MAUDE reports
19
reports, 12 months to August 2026
20 in the 12 months before
27.2%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code OQG is FDA's classification for "Hip prosthesis, semi-constrained, cemented, metal/polymer, + additive, porous, uncemented" (orthopedic panel), a class 2 device. 673 medical device reports carry this product code, 0% of the MAUDE database, from September 2004 to July 2026.

19 reports arrived in the 12 months to August 2026, close to the 20 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (72.2%), malfunction (27.2%) and other (0.4%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
X-Alt Hip17100%0.6%
Fmp Hip2100%3.3%
M2a-Magnum Pf Cup 56odx50id2110%0.2%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Encore Medical L P17726.3%
Mako Surgical9414%
Biomet UK334.9%
Conformis10.1%

Reports by month, five years

047Sep 2021: 6Oct 2021: 6Nov 2021: 1Dec 2021: 52022Jan 2022: 5Feb 2022: 7Mar 2022: 1Apr 2022: 5May 2022: 2Jun 2022: 0Jul 2022: 0Aug 2022: 3Sep 2022: 3Oct 2022: 0Nov 2022: 4Dec 2022: 22023Jan 2023: 1Feb 2023: 1Mar 2023: 2Apr 2023: 0May 2023: 1Jun 2023: 1Jul 2023: 4Aug 2023: 1Sep 2023: 2Oct 2023: 1Nov 2023: 2Dec 2023: 22024Jan 2024: 1Feb 2024: 3Mar 2024: 1Apr 2024: 2May 2024: 1Jun 2024: 0Jul 2024: 4Aug 2024: 2Sep 2024: 0Oct 2024: 2Nov 2024: 0Dec 2024: 42025Jan 2025: 1Feb 2025: 3Mar 2025: 1Apr 2025: 1May 2025: 3Jun 2025: 1Jul 2025: 3Aug 2025: 1Sep 2025: 0Oct 2025: 1Nov 2025: 0Dec 2025: 12026Jan 2026: 1Feb 2026: 1Mar 2026: 4Apr 2026: 3May 2026: 3Jun 2026: 3Jul 2026: 2Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%0
Injury72.2%486
Malfunction27.2%183
Other0.4%3
Not given0.1%1

Who filed

Manufacturer report99.3%668
Voluntary report0.1%1
User facility report0%0
Distributor report0.4%3
Not given0.1%1

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Device dislodged or dislocated8813.1%
Insufficient device problem information7511.1%
Device contaminated during manufacture or shipping6910.3%
Unstable324.8%
Breakthe device broke284.2%
Fracturea broken bone182.7%
Material integrity problema problem with the device material162.4%
Difficult to insertthe device was hard to insert131.9%
Packaging problem121.8%
Patient device interaction problem111.6%
Manufacturing, packaging or shipping problem91.3%
Inadequacy of device shape and/or size81.2%
Unintended movement81.2%
Device operates differently than expectedthe device behaved unexpectedly71%
Detachment of device or device componentpart of the device came off60.9%
Loose or intermittent connection60.9%
Loosening of implant not related to bone-ingrowth60.9%
Material deformation60.9%
Mechanical problema mechanical problem60.9%
Naturally worn60.9%

Questions about hip prosthesis, semi-constrained, cemented, metal/polymer, + additive, porous, uncemented reports

What is product code OQG?

FDA's classification code for "Hip prosthesis, semi-constrained, cemented, metal/polymer, + additive, porous, uncemented", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.

How many reports carry this code?

673 reports through August 2026, 19 of them in the latest 12 months.

Which brands appear most often?

X-Alt Hip (171), Fmp Hip (21) and M2a-Magnum Pf Cup 56odx50id (2). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.